caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1467734889

Jason BleazardO.D.

PRACTICECOLUMBIA BASIN HEALTH ASSOCIATIONSee all providers at this practice →
OptometryOthello, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
176
Beneficiaries
—
Total drug cost
$8K
Distinct drugs
7
Brand share
23.9%
Top prescribed drugs
Latanoprost73 claims
Dorzolamide Hcl/Timolol Maleat24 claims
Prednisolone Acetate19 claims
Neomycin/Polymyxin B/Dexametha18 claims
Brimonidine Tartrate15 claims
REFERRAL NETWORK

Where Jason Bleazard's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
COLUMBIA BASIN HEALTH ASSOCIATION1942
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
COLUMBIA BASIN HEALTH ASSOCIATION3366
Interpath Laboratory, Inc.
Clinical Laboratory · Pendleton, OR
27109
COLUMBIA BASIN HEALTH ASSOCIATION1738
COLUMBIA BASIN HEALTH ASSOCIATION1320
KADLEC REGIONAL MEDICAL CENTER1320
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.